These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 8618238)
1. Impact of inclusion of subsequent primary cancers on estimates of risks of developing cancer. Morris CR; Perkins CI; Wright WE; Snipes KP; Young JL J Natl Cancer Inst; 1996 Apr; 88(7):456-8. PubMed ID: 8618238 [No Abstract] [Full Text] [Related]
2. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study. Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004 [TBL] [Abstract][Full Text] [Related]
3. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991. McCredie M; Macfarlane GJ; Bell J; Coates M Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657 [TBL] [Abstract][Full Text] [Related]
4. Other primary systemic cancers in patients with melanoma: Analysis of balanced acral and nonacral melanomas. Bae SH; Seon HJ; Choi YD; Shim HJ; Lee JB; Yun SJ J Am Acad Dermatol; 2016 Feb; 74(2):333-40. PubMed ID: 26584878 [TBL] [Abstract][Full Text] [Related]
5. Risk of second primary malignancies in women with papillary thyroid cancer. Canchola AJ; Horn-Ross PL; Purdie DM Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240 [TBL] [Abstract][Full Text] [Related]
6. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk? Wu GX; Nelson RA; Kim JY; Raz DJ Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093 [TBL] [Abstract][Full Text] [Related]
7. Cancer incidence trends in white women of the San Francisco Bay Area. Austin DF; King M; Roe K Natl Cancer Inst Monogr; 1979 Nov; (53):95-101. PubMed ID: 537638 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers. Leu M; Reilly M; Czene K J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865 [TBL] [Abstract][Full Text] [Related]
9. The prediction of cancer incidence in Finland for the year 1980 by means of cancer registry material. Teppo L; Hakulinen T; Saxén E Ann Clin Res; 1974 Apr; 6(2):122-5. PubMed ID: 4837884 [No Abstract] [Full Text] [Related]
10. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857 [TBL] [Abstract][Full Text] [Related]
11. Incidence of invasive cancers following squamous cell skin cancer. Levi F; Randimbison L; La Vecchia C; Erler G; Te VC Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621 [TBL] [Abstract][Full Text] [Related]
12. Regional variations in breast cancer incidence among California women, 1988-1997. Reynolds P; Hurley SE; Quach AT; Rosen H; Von Behren J; Hertz A; Smith D Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455 [TBL] [Abstract][Full Text] [Related]
13. Lung cancer risks in women with previous breast cancer. Prochazka M; Granath F; Ekbom A; Shields PG; Hall P Eur J Cancer; 2002 Jul; 38(11):1520-5. PubMed ID: 12110499 [TBL] [Abstract][Full Text] [Related]
14. Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009. Aben KK; van Gaal C; van Gils NA; van der Graaf WT; Zielhuis GA Acta Oncol; 2012 Sep; 51(7):922-33. PubMed ID: 22934554 [TBL] [Abstract][Full Text] [Related]
15. Familial risk in patients with carcinoma of unknown primary. Baker H Lancet Oncol; 2016 Feb; 17(2):e48. PubMed ID: 26723087 [No Abstract] [Full Text] [Related]
16. Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Dong C; Hemminki K Int J Cancer; 2001 Jun; 92(6):883-7. PubMed ID: 11351311 [TBL] [Abstract][Full Text] [Related]
17. Second primary cancers in the Vaud and Neuchâtel Cancer Registries. Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586 [TBL] [Abstract][Full Text] [Related]
18. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009. van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461 [TBL] [Abstract][Full Text] [Related]
19. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study. Gromowski T; Masojć B; Scott RJ; Cybulski C; Górski B; Kluźniak W; Paszkowska-Szczur K; Rozmiarek A; Dębniak B; Maleszka R; Kładny J; Lubiński J; Dębniak T Cancer Genet; 2014 Apr; 207(4):128-32. PubMed ID: 24767713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]